Financial Performance - The company's revenue for the year ended December 31, 2025, was approximately RMB 2,657.4 million, a decrease of about RMB 626.8 million or approximately 19.1% compared to the same period in 2024[2]. - Gross profit for the year ended December 31, 2025, was approximately RMB 319.5 million, down by about RMB 76.7 million or approximately 19.4% year-over-year[2]. - Net profit for the year ended December 31, 2025, was approximately RMB 62.5 million, a decrease of about RMB 60.5 million or approximately 49.2% compared to 2024[2]. - Basic and diluted earnings per share attributable to ordinary equity holders of the parent for the year ended December 31, 2025, was approximately RMB 0.67, down by about RMB 0.78 or approximately 53.8% from the previous year[2]. - Total comprehensive income for the year ended December 31, 2025, was RMB 62.4 million, compared to RMB 123.2 million in 2024[6]. - Total revenue for 2025 was RMB 2,657,358,000, a decrease of 19% from RMB 3,284,183,000 in 2024[35]. - The company’s net profit attributable to equity holders decreased by approximately 49.2% to about RMB 62.5 million, down from RMB 123.0 million in 2024[83]. - The gross profit margin for the group was approximately 12.0%, slightly down from 12.1% in 2024[94]. Dividends - The board proposed a final dividend of RMB 0.3215 per ordinary share for the year ended December 31, 2025, subject to shareholder approval at the annual general meeting[2]. - The proposed final dividend for 2025 is RMB 0.3215 per share, compared to RMB 0.4823 per share in 2024, a reduction of 33.4%[52]. - The board proposed a final dividend of RMB 0.3215 per share for the year ending December 31, 2025, subject to shareholder approval at the annual general meeting on May 20, 2026, with a total dividend payout of approximately RMB 30 million[127]. Assets and Liabilities - Non-current assets as of December 31, 2025, totaled RMB 1,679.5 million, an increase from RMB 1,401.5 million in 2024[7]. - Current assets as of December 31, 2025, amounted to RMB 960.9 million, slightly up from RMB 950.2 million in 2024[7]. - Total liabilities as of December 31, 2025, were RMB 1,550.6 million, compared to RMB 1,574.9 million in 2024, indicating a decrease in current liabilities[8]. - The company's net assets as of December 31, 2025, were RMB 691.4 million, an increase from RMB 673.6 million in 2024[8]. - Total current liabilities of the group amounted to approximately RMB 1,550.6 million, a decrease from RMB 1,575.0 million as of December 31, 2024[115]. Cash Flow - Operating cash flow for the year ended December 31, 2025, was RMB 41,723 thousand, a significant decrease from RMB 262,508 thousand in 2024[12]. - The company reported a net cash outflow from investing activities of RMB 322,823 thousand, compared to RMB 61,441 thousand in the previous year[13]. - Financing activities generated a net cash inflow of RMB 332,564 thousand, reversing a net cash outflow of RMB 192,948 thousand in 2024[14]. - The total cash and cash equivalents at the end of 2025 increased to RMB 125,042 thousand from RMB 73,680 thousand in 2024[14]. Inventory and Receivables - The company reported a significant increase in inventory, with a rise of RMB 35,660 thousand in 2025 compared to a smaller increase of RMB 6,583 thousand in 2024[12]. - Total inventory as of December 31, 2025, was RMB 328,085,000, an increase from RMB 292,403,000 in 2024[61]. - Trade receivables amounted to RMB 119,214,000, down from RMB 154,044,000 in the previous year[61]. - The provision for impairment losses on trade receivables increased to RMB 1,429 thousand in 2025 from RMB 1,410 thousand in 2024, indicating a slight rise of 1.3%[68]. Expenses - Research and development expenses for 2025 are RMB 132,092,000, slightly down from RMB 137,994,000 in 2024, a decrease of 4.0%[42]. - Sales and distribution expenses were approximately RMB 22.9 million, down by about RMB 1.5 million from RMB 24.4 million in the same period of 2024, representing 0.9% of total revenue[97]. - Administrative expenses were approximately RMB 106.2 million, a decrease of about RMB 12.2 million from RMB 118.4 million in the same period of 2024, accounting for 4.0% of total revenue[98][99]. - R&D expenses were approximately RMB 132.1 million, down by about RMB 5.9 million from RMB 138.0 million in the same period of 2024, representing 5.0% of total revenue[100][101]. Regulatory Compliance - The group has adopted the revised Hong Kong Accounting Standard No. 21, which clarifies how to assess the convertibility of currencies and requires disclosures related to currency non-convertibility impacts[21]. - The group has not early adopted any other issued but not yet effective standards or amendments, indicating a focus on compliance with current regulations[22]. - The company expects that the amendments to the Hong Kong Financial Reporting Standards will not have a significant impact on the financial statements[30]. - The company clarified that the amendments to the financial reporting standards are expected to be applied retrospectively and will not require restatement of prior periods[28]. Employee Information - The group’s total employee costs for the reporting period were approximately RMB 106.8 million, a decrease from RMB 123.9 million for the year ended December 31, 2024, mainly due to a reduction in employee bonuses corresponding to the group's performance[125]. - As of December 31, 2025, the group had 638 employees, an increase from 626 employees as of December 31, 2024[125]. Future Plans - The company plans to invest in the Hubei Xuanhong production base, with a second phase expansion expected to start construction in the second half of 2025, aiming for a production capacity of 160,000 tons/year for toluene chlorination products[93]. - The company aims to optimize product sales strategies and expand its global sales and marketing network to enhance market penetration and supply chain resilience[93].
武汉有机(02881) - 2025 - 年度业绩